Genpact LTD - 8-K Filing
Genpact reports Q3 2026 net revenue of $1.385B and raises full-year gross margin and adjusted EPS guidance. (Items: 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or ot)
Tickers: $G
Read the full article at SEC EDGAR
Part of the story IDEXX LABORATORIES INC /DE - 8-K Filing (5 articles)